Bilakhia Family, Bilakhia Holdings, Bilakhia Group

The Genome is the written code that creates life. At Micro we redesign it, to give life more meaning.

Living Therapeutics:

At Micro, we use advanced genome editing technologies to make living therapeutics that will revolutionise the future of medicine. After all, the body knows best how to repair and defend itself. We strive to bring about a world where people no longer need to fear diseases like Cancer, neurodegeneration, metabolic disorders and HIV. Our current line-up, while ambitious, is only the first step we are taking towards our vision of a disease free world.

Bilakhia Family, Bilakhia Holdings, Bilakhia Group

Xenotransplantation:

The gap between the number of organ donors and organ recipients has never been wider- and its worsening! Furthermore, most transplants deteriorate over time even after taking immune suppressive medication due to rejection from the patients’ body. Because of this transplants do not tend to last for the duration of the patients’ life. There is a need for radical innovation in transplantation technology in order to create a solution. At Micro, we believe that through harnessing the power of CRISPR, xenotransplantation is that solution.

Bilakhia Family, Bilakhia Holdings, Bilakhia Group

Agriculture:

Current agriculture techniques are unsustainable and will not be able to keep up with a world that is growing more unpredictable by the day. . At Micro, we believe that the only solution to this global crisis is to harness the power of gene-editing technology and giving plants the ability to evolve at the rate the planet is evolving today. Furthermore, we intend to supplement this technology with other concepts such as vertical farming, artificial intelligence and a lot more.

Bilakhia Family, Bilakhia Holdings, Bilakhia Group